Loading clinical trials...

Clareo Health

Your health journey, clearly organized.

Find Clinical Trials →

Legal

What Happens to First Trimester Nuchal Translucency | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04541966

What Happens to First Trimester Nuchal Translucency

First trimester nuchal translucency is a call point for genetic abnormalities and birth defects. Nuchal translucency varies with LCC and therefore with gestational age as described by Chung et al who ...

Lead sponsor: University Hospital, Montpellier•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment230

Start dateMay 2020

Last updatedSep 10, 2020

Condition

Nuchal Translucency

Locations shown

Uhmontpellier

Montpellier

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 10, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions